tirzepatide a glp1 GLP-1/GIP Rx glp-1 tirzepatide FDA Ruling on
Description
The answer is more complicated than a simple yes or no

For users considering switching between GLP-1 medications , current evidence does not support choosing one over another specifically to reduce blood clot risk

Personalized formulations support metabolism, appetite control, and sustainable weight goals

Semaglutide does not inherently cause thyroid dysfunction, but the rapid weight loss it enables can mobilize stored thyroid hormones, temporarily elevating TSH or free T4 levels
